| Type | MGI:General | Description | pancreatic human amylin and hence, total amylin, is elevated before diabetes development pancreatic glucagon is elevated at the end-diabetic stage mouse amylin levels are elevated before diabetes onset, however, pancreatic mouse amylin concentrations are decreased at the mid- and end-diabetic stages pancreatic insulin levels are decreased at mid- and end-diabetic stages |
